75 studies found for:    "Valganciclovir"
Show Display Options
Rank Status Study
1 Completed
Has Results
Valganciclovir to Reduce T Cell Activation in HIV Infection
Conditions: HIV Infections;   Cytomegalovirus Infections
Interventions: Drug: Valganciclovir;   Drug: Placebo
2 Completed
Has Results
IMPACT Study: A Study of Valcyte (Valganciclovir) for Prevention of Cytomegalovirus Disease (CMV) in Kidney Allograft Recipients
Condition: Cytomegalovirus Infections
Intervention: Drug: Valganciclovir
3 Recruiting ValGanciclovir Versus ValAcyclovir for Viral Prophylaxis in Kidney Transplantation
Conditions: Transplantation Infection;   Epstein-Barr Virus Infections;   Cytomegalovirus Infections
Interventions: Drug: Valacyclovir;   Drug: Valganciclovir
4 Terminated Study Comparing Valganciclovir Versus Ganciclovir in Patients Following Allogeneic Stem Cell Transplantation
Condition: Allogeneic Stem Cell Transplantation
Interventions: Drug: Valganciclovir;   Drug: Ganciclovir
5 Completed Valganciclovir for Treatment of Cytomegalovirus Infection in Solid Organ Transplant Patients
Condition: Cytomegalovirus Infection
Intervention: Drug: Single arm (ganciclovir and valganciclovir)
6 Not yet recruiting Evaluation of the Benefit of Antiviral Treatment With Valganciclovir on Congenital CMV Infection-related Deafness on Hearing and Balance
Condition: Congenital Cytomegalovirus (CMV)
Intervention: Drug: Valganciclovir
7 Completed Bioavailability Study of Valganciclovir Hydrochloride Tablets 450 mg Under Fed Condition
Condition: Healthy
Intervention: Drug: Valganciclovir Hydrochloride
8 Completed Bioavailability Study of Valganciclovir Hydrochloride Tablets 450 mg Under Fasting Condition
Condition: Healthy
Intervention: Drug: Valganciclovir Hydrochloride
9 Completed Individualization of Ganciclovir and Valganciclovir Doses Using Bayesian Prediction in Renal Transplant Patients.
Condition: Infection in Solid Organ Transplant Recipients
Interventions: Drug: Ganciclovir/ Valganciclovir according to SPC;   Drug: Ganciclovir/ Valganciclovir according to PK model
10 Active, not recruiting Cytogam Administration in Abdominal Organ Transplant Recipients at High Risk for Cytomegalovirus Infection
Condition: Cytomegalovirus Disease
Interventions: Drug: Valganciclovir;   Biological: CMV hyperimmune globulin
11 Completed
Has Results
Short-Term vs. Long-Term Valganciclovir Therapy for Symptomatic Congenital CMV Infections
Condition: Cytomegalovirus Infection
Interventions: Other: Placebo;   Drug: Valganciclovir
12 Completed Valganciclovir in Congenital CMV Infants
Condition: Cytomegalovirus Infections
Interventions: Drug: Valganciclovir;   Drug: Ganciclovir
13 Recruiting Valganciclovir Dosing in Pediatric Solid Organ Transplant Recipients
Condition: Infection in Solid Organ Transplant Recipients
Intervention: Drug: prophylactic Valganciclovir
14 Completed
Has Results
Treating Kidney Donors With Valganciclovir to Reduce Viral Transmission to Recipients
Conditions: EBV Viremia;   CMV Viremia
Interventions: Drug: Valganciclovir;   Drug: Placebo
15 Recruiting Congenital Cytomegalovirus: Efficacy of Antiviral Treatment
Conditions: Congenital Cytomegalovirus Infection;   Sensorineural Hearing Loss
Intervention: Drug: Valganciclovir
16 Terminated Congenital Cytomegalovirus: Efficacy of Antiviral Treatment in a Randomized Controlled Trial
Conditions: Congenital Cytomegalovirus Infection;   Sensorineural Hearing Loss
Intervention: Drug: Valganciclovir
17 Completed Oral Valganciclovir Versus Valacyclovir
Conditions: Chronic Lymphocytic Leukemia;   Leukemia
Interventions: Drug: Valganciclovir;   Drug: Valacyclovir
18 Withdrawn Valganciclovir to Treat HHV-8 Associated Multicentric Castleman's Disease
Condition: Giant Lymph Node Hyperplasia
Intervention: Drug: Valganciclovir
19 Completed
Has Results
Comparison of Oral Valganciclovir and Placebo for the Prevention of Cytomegalovirus (CMV) After Lung Transplantation
Condition: Cytomegalovirus Infections
Interventions: Drug: valganciclovir;   Other: Placebo
20 Completed
Has Results
Valganciclovir in Treating Patients With Classic Non-HIV-Associated Kaposi's Sarcoma
Condition: Sarcoma
Intervention: Drug: valganciclovir

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Indicates status has not been verified in more than two years